Leading Overseas Installations and Global Expansion Methodology of Suntech Medical, the Pioneer in Blood Purification Equipment [2025 VBEF]

“Go global or go extinct” was once hailed as the strategic anchor for pharmaceutical and medical device companies. Today, however, the logic behind Chinese healthcare firms’ global expansion is being reshaped amid tariff disputes. “How to go global” has become a critical question that enterprises must urgently address on their path to development.

Amid this industry transformation, Chongqing Shanwaishan Science&Technology Co.,Ltd. (hereinafter referred to as “SWS MEDICAL”) has provided the sector with a strategic model through its unique overseas expansion paradigm.

At the main forum of the 2025 VBEF Future Healthcare & Pharma Top 100 Exhibition, Gao Guangyong, Chairman of SWS MEDICAL, drew on the company’s development practices and combined them with industry trends to reveal the underlying logic and future direction for Chinese-made high-end medical equipment going global.

Gao Guangyong, Chairman of SWS MEDICAL

As the third major clinical treatment modality following pharmacotherapy and surgery, blood purification equipment has long been monopolized by overseas companies. Achieving technological breakthroughs in this field has proven exceptionally difficult. Not only do regulatory bodies such as the National Medical Products Administration (NMPA) impose stringent oversight, but companies also face the challenge of overcoming multidisciplinary technical barriers in materials science, fluid dynamics, and biomedical engineering amid technology blockades. Under these compounding challenges, blood purification equipment has become one of the high-end medical device sectors with the slowest progress in domestic substitution in China.

Today, driven by Chinese blood purification enterprises, blood purification technology is undergoing a transformation from “domestic substitution” to “technological feedback.”SWS MEDICAL, the first company in China’s blood purification industry to be listed on the STAR Market, has spent over two decades pioneering a path to breakthrough success through independent innovation and the construction of a full-industry-chain ecosystem.

SWS MEDICAL has always regarded the R&D of key technologies for continuous blood purification equipment and hemodialysis machines as its core breakthrough strategy.The company has conducted in-depth research and technological innovation across the entire system, control software, core algorithms, as well as equipment components and specialized sensors.

Meanwhile, SWS MEDICAL has established a series of platforms, including a National Enterprise Technology Center, a National-Local Joint Engineering Research Center, and a National Postdoctoral Research Station, to overcome key core technologies in the blood purification industry. In terms of overall quality, its products have achieved parity with imported brands of the same category, surpassing imported equipment in certain indicators, thereby ultimately realizing domestic substitution in the field of blood purification equipment.

Breakthroughs in core technologies have also laid the foundation for the company’s market expansion.SWS MEDICAL not only developed China’s first online hemodiafiltration machine, but also launched the SWS-5000 series, which integrates CRRT (continuous renal replacement therapy), artificial liver support, and plasma exchange functions, placing its therapeutic capabilities among the global leaders in similar products. Leveraging breakthroughs in proprietary technologies, SWS MEDICAL retained its position as the sales champion in the Chinese market for two consecutive years from 2023 to 2024.

Furthermore, as a leading enterprise in the blood purification industry, the Company spearheaded the establishment of the China Blood Purification Technology Innovation Strategic Alliance and serves as its chairman unit. In 2023, it facilitated the formation of the Blood Purification Professional Committee under the China Association for Medical Devices, further promoting collaborative innovation among industry, academia, research, and clinical practice, as well as advancing the development of China’s blood purification sector.

In summary, technology has always been the core driving force throughout the entire development chain of SWS MEDICAL. Guided by this logical thread, the company ultimately achieved a leap from equipment R&D, market expansion, and industry influence building to whole-industry-chain layout and global brand creation.

Expanding overseas not only signifies access to vast market opportunities but also entails addressing multiple challenges, including regulatory disparities, cultural barriers, talent acquisition difficulties, intensified market competition, differences in consumer habits, and after-sales service. Therefore, strategic planning for overseas markets is crucial, as its effectiveness directly determines the depth and breadth of a company’s globalization process.

In its journey toward globalization, SWS MEDICAL has achieved a qualitative leap from exporting products to exporting technical standards.

Today, the company’s products cover more than 100 countries and regions, with overseas installations exceeding 10,000 units. Over 6,000 medical institutions worldwide have formed a stable user base, and the compound annual growth rate (CAGR) of overseas revenue has exceeded 50% in the past five years. Notably, through hundreds of overseas technical exchanges and training activities, SWS MEDICAL has actively promoted the alignment and integration of Chinese blood purification technology standards with international diagnostic and treatment systems. The related achievements have been recognized and recommended by international professional organizations and have been applied in certain international medical aid projects.

At the conference, Gao Guangyong shared his insights on global expansion:

First, build a diverse talent team to address challenges such as cultural barriers.Talent is the core driving force behind enterprises’ global expansion. By building multilingual technical support teams, localized teams, and teams with diverse professional backgrounds, companies can overcome language and cultural barriers, gain a deep understanding of overseas market demands and regulatory differences, and provide a solid foundation for the successful deployment of their products and services abroad.

Second, innovate business models to build a competitive advantage in service delivery.SWS MEDICAL has transcended the single-equipment export model, establishing a digital, end-to-end, high-efficiency innovation service system. With rapid response capabilities to meet customer needs, it has built a reputation for reliable service.

Third, digital marketing for precise traffic acquisition and market expansion.By leveraging diversified marketing platforms, formulating precise outreach strategies tailored to market characteristics, and utilizing localized platforms and advertising campaigns for traffic acquisition, we aim to enhance international market awareness.

Fourth, adhere to long-termism and accumulate brand value.SWS MEDICAL continues to embody the philosophy of “being friends with time” through its actions. Since embarking on its global expansion journey in 2006, 18 years of accumulation have enabled SWS MEDICAL to build profound expertise in the hemodialysis field. This depth of experience has even broken the blockade and monopoly imposed by multinational corporations on the global blood purification market. From growing alongside customers in India to securing proactive strategic partnerships with collaborators in the Philippines, these long-term, stable relationships have allowed SWS MEDICAL to break international monopolies and cultivate strong brand loyalty.

5. Uphold win-win cooperation to expand market presence.Guided by a commitment to long-term cooperation and mutual benefit, SWS MEDICAL has moved from the periphery to the center in multiple international markets. Leveraging cost-effective products and high-quality services, the company has successfully served numerous chain dialysis centers and achieved large-scale installations across various regions, vividly demonstrating the robust vitality of the win-win cooperation model.

Sixth, build a strong reputation and enhance international influence.SWS MEDICAL has garnered recognition across industry-academia-research collaborations, among users, and within government circles. Under the framework of the Belt and Road Initiative, the company has empowered the development of blood purification medical systems in participating countries through technology export, establishing itself as a benchmark case for Chinese medical equipment going global. Meanwhile, SWS MEDICAL actively participates in international medical aid and United Nations Development Programme projects, engaging in global humanitarian medical rescue efforts. By deeply integrating advanced Chinese solutions with global healthcare needs, the company demonstrates the scientific innovation strength and social responsibility of China’s high-end medical device sector.

When the lever of the era crosses a threshold, even the slightest force can tip the entire structure. SWS MEDICAL’s global expansion not only illustrates this principle but also serves as a microcosm of Chinese manufacturing breaking through prejudices and overcoming formidable barriers. By placing technological innovation at its core, the company has unlocked the door to international markets, securing its own growth space while providing a replicable success model for other Chinese medical device enterprises seeking to go global.